Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation
International Journal of Laboratory Hematology · 2024-02 · 46 (1) · 5-7
DOI: 10.1111/ijlh.14167 ↗At a glance
Fallbericht in International Journal of Laboratory Hematology, published online on 2023-09-06. Written by Shuyu E and 3 co-authors. Institution: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Major MEDLINE topics: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid. Cited 1 times so far (Crossref); 3 references.
Abstract (original language)
The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID profiles: C Cameron Yin
Cite
APA
E, S., Nahmod, K. A., Wang, S. A., & Yin, C. C. (2024). Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation. International Journal of Laboratory Hematology, 46(1), 5-7. https://doi.org/10.1111/ijlh.14167
Vancouver
E S, Nahmod KA, Wang SA, Yin CC. Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation. International Journal of Laboratory Hematology. 2024;46(1):5-7. doi:10.1111/ijlh.14167
BibTeX
@article{E2024,
author = {E, Shuyu and Nahmod, Karen A and Wang, Sa A and Yin, C Cameron},
title = {Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation},
journal = {International Journal of Laboratory Hematology},
year = {2024},
volume = {46},
number = {1},
pages = {5--7},
doi = {10.1111/ijlh.14167}
}
EUVIMED